In the high-stakes world of gene therapy, Barcelona-based SpliceBio has carved a unique path by focusing on delivering replacement proteins for mutated genes. This innovative approach is a refreshing departure from traditional gene splicing or editing techniques, and it’s making waves in the biotech community. At the heart of their groundbreaking work is SB-007, a […]
Tag: viral
Advancements in Viral Vector Manufacturing
The recent Viral Manufacturing and Translational Consortium (VMTC) held at The Hormel Institute, University of Minnesota, showcased the latest innovations in viral vector manufacturing. Bringing together experts from academia and industry, the event highlighted cutting-edge techniques and technologies being utilized to improve the production of viral vectors for various applications including gene therapy, vaccine development, […]
Pharma Giant Bristol Myers Squibb Shuts Down Viral Vector Production Facility in Illinois
In a strategic move, Bristol Myers Squibb, a leading pharmaceutical company, has announced the closure of its viral vector production facility in Libertyville, Illinois. This decision is part of a larger consolidation effort to streamline its cell therapy manufacturing operations. The company plans to transfer vector production to its Devens, Massachusetts facility to enhance cost-effectiveness […]